What is new in the management of wet age-related macular degeneration?

Author： Sivaprasad Sobha   Hykin Philip  

Publisher： Oxford University Press

ISSN： 1471-8391

Source： British Medical Bulletin, Vol.105, Iss.1, 2013-03, pp. : 201-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A systematic literature review of utility weights in wet age-related macular degeneration

By Pearson Isobel   Rycroft Catherine   Irving Adam   Ainsworth Claire   Wittrup-Jensen Kim  

Journal of Medical Economics, Vol. 16, Iss. 11, 2013-11 ,pp. : 1307-1316

Informa Healthcare

Access to resources Recommend Favorite

One‐Year Effectiveness Study of Intravitreous Ranibizumab in Wet (Neovascular) Age‐Related Macular Degeneration: A Meta‐Analysis

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 38, Iss. 2, 2018-02 ,pp. : 197-204

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti‐vascular endothelial growth factors treatment of wet age‐related macular degeneration: from neurophysiology to cost‐effectiveness

By  

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. A109, 2018-02 ,pp. : 1-46

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recent advances in the treatment of age-related macular degeneration

By Solebo Ameenat Lola   Angunawela Romesh I   Dasgupta Samipa   Marshall John  

British Journal of General Practice, Vol. 58, Iss. 550, 2008-05 ,pp. : 309-310

Royal College of General Practitioners

Access to resources Recommend Favorite

Age-related macular degeneration: an overview and update

By Lip PL   Menon VJK  

Therapy, Vol. 3, Iss. 3, 2006-05 ,pp. : 417-424

Future Medicine

Access to resources Recommend Favorite